These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 25538019

  • 1. Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.
    Herman JM, Chang DT, Goodman KA, Dholakia AS, Raman SP, Hacker-Prietz A, Iacobuzio-Donahue CA, Griffith ME, Pawlik TM, Pai JS, O'Reilly E, Fisher GA, Wild AT, Rosati LM, Zheng L, Wolfgang CL, Laheru DA, Columbo LA, Sugar EA, Koong AC.
    Cancer; 2015 Apr 01; 121(7):1128-37. PubMed ID: 25538019
    [Abstract] [Full Text] [Related]

  • 2. Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.
    Gurka MK, Collins SP, Slack R, Tse G, Charabaty A, Ley L, Berzcel L, Lei S, Suy S, Haddad N, Jha R, Johnson CD, Jackson P, Marshall JL, Pishvaian MJ.
    Radiat Oncol; 2013 Mar 01; 8():44. PubMed ID: 23452509
    [Abstract] [Full Text] [Related]

  • 3. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer.
    Schellenberg D, Goodman KA, Lee F, Chang S, Kuo T, Ford JM, Fisher GA, Quon A, Desser TS, Norton J, Greco R, Yang GP, Koong AC.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):678-86. PubMed ID: 18395362
    [Abstract] [Full Text] [Related]

  • 4. Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer.
    Rao AD, Sugar EA, Chang DT, Goodman KA, Hacker-Prietz A, Rosati LM, Columbo L, O'Reilly E, Fisher GA, Zheng L, Pai JS, Griffith ME, Laheru DA, Iacobuzio-Donahue CA, Wolfgang CL, Koong A, Herman JM.
    Pract Radiat Oncol; 2016 Nov 01; 6(6):417-424. PubMed ID: 27552809
    [Abstract] [Full Text] [Related]

  • 5. Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration.
    Polistina F, Costantin G, Casamassima F, Francescon P, Guglielmi R, Panizzoni G, Febbraro A, Ambrosino G.
    Ann Surg Oncol; 2010 Aug 01; 17(8):2092-101. PubMed ID: 20224860
    [Abstract] [Full Text] [Related]

  • 6. Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer.
    Schellenberg D, Kim J, Christman-Skieller C, Chun CL, Columbo LA, Ford JM, Fisher GA, Kunz PL, Van Dam J, Quon A, Desser TS, Norton J, Hsu A, Maxim PG, Xing L, Goodman KA, Chang DT, Koong AC.
    Int J Radiat Oncol Biol Phys; 2011 Sep 01; 81(1):181-8. PubMed ID: 21549517
    [Abstract] [Full Text] [Related]

  • 7. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer.
    Mahadevan A, Jain S, Goldstein M, Miksad R, Pleskow D, Sawhney M, Brennan D, Callery M, Vollmer C.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):735-42. PubMed ID: 20171803
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcomes and prognostic factors of stereotactic body radiation therapy combined with gemcitabine plus capecitabine for locally advanced unresectable pancreatic cancer.
    Shen ZT, Zhou H, Li AM, Ji XQ, Jiang CC, Yuan X, Li B, Zhu XX, Huang GC.
    J Cancer Res Clin Oncol; 2020 Feb 01; 146(2):417-428. PubMed ID: 31667573
    [Abstract] [Full Text] [Related]

  • 9. SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience.
    Tozzi A, Comito T, Alongi F, Navarria P, Iftode C, Mancosu P, Reggiori G, Clerici E, Rimassa L, Zerbi A, Fogliata A, Cozzi L, Tomatis S, Scorsetti M.
    Radiat Oncol; 2013 Jun 21; 8():148. PubMed ID: 23799996
    [Abstract] [Full Text] [Related]

  • 10. Multiagent Chemotherapy and Stereotactic Body Radiation Therapy in Patients with Unresectable Pancreatic Adenocarcinoma: A Prospective Nonrandomized Controlled Trial.
    Hill CS, Rosati L, Wang H, Tsai HL, He J, Hacker-Prietz A, Laheru DA, Zheng L, Sehgal S, Bernard V, Le DT, Pawlik TM, Weiss MJ, Narang AK, Herman JM.
    Pract Radiat Oncol; 2022 Jun 21; 12(6):511-523. PubMed ID: 35306231
    [Abstract] [Full Text] [Related]

  • 11. Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial.
    Zhu X, Cao Y, Liu W, Ju X, Zhao X, Jiang L, Ye Y, Jin G, Zhang H.
    Lancet Oncol; 2021 Aug 21; 22(8):1093-1102. PubMed ID: 34237249
    [Abstract] [Full Text] [Related]

  • 12. Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer.
    Wild AT, Herman JM, Dholakia AS, Moningi S, Lu Y, Rosati LM, Hacker-Prietz A, Assadi RK, Saeed AM, Pawlik TM, Jaffee EM, Laheru DA, Tran PT, Weiss MJ, Wolfgang CL, Ford E, Grossman SA, Ye X, Ellsworth SG.
    Int J Radiat Oncol Biol Phys; 2016 Mar 01; 94(3):571-9. PubMed ID: 26867885
    [Abstract] [Full Text] [Related]

  • 13. Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta-analysis.
    Tchelebi LT, Lehrer EJ, Trifiletti DM, Sharma NK, Gusani NJ, Crane CH, Zaorsky NG.
    Cancer; 2020 May 15; 126(10):2120-2131. PubMed ID: 32125712
    [Abstract] [Full Text] [Related]

  • 14. Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy.
    Dholakia AS, Chaudhry M, Leal JP, Chang DT, Raman SP, Hacker-Prietz A, Su Z, Pai J, Oteiza KE, Griffith ME, Wahl RL, Tryggestad E, Pawlik T, Laheru DA, Wolfgang CL, Koong AC, Herman JM.
    Int J Radiat Oncol Biol Phys; 2014 Jul 01; 89(3):539-46. PubMed ID: 24751410
    [Abstract] [Full Text] [Related]

  • 15. Image-guided stereotactic radiosurgery for locally advanced pancreatic adenocarcinoma results of first 85 patients.
    Didolkar MS, Coleman CW, Brenner MJ, Chu KU, Olexa N, Stanwyck E, Yu A, Neerchal N, Rabinowitz S.
    J Gastrointest Surg; 2010 Oct 01; 14(10):1547-59. PubMed ID: 20839073
    [Abstract] [Full Text] [Related]

  • 16. AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer.
    Oar A, Lee M, Le H, Wilson K, Aiken C, Chantrill L, Simes J, Nguyen N, Barbour A, Samra J, Sjoquist KM, Moore A, Espinoza D, Gebski V, Yip S, Chu J, Kneebone A, Goldstein D.
    BMC Cancer; 2021 Aug 19; 21(1):936. PubMed ID: 34412605
    [Abstract] [Full Text] [Related]

  • 17. The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience.
    Moningi S, Dholakia AS, Raman SP, Blackford A, Cameron JL, Le DT, De Jesus-Acosta AM, Hacker-Prietz A, Rosati LM, Assadi RK, Dipasquale S, Pawlik TM, Zheng L, Weiss MJ, Laheru DA, Wolfgang CL, Herman JM.
    Ann Surg Oncol; 2015 Jul 19; 22(7):2352-8. PubMed ID: 25564157
    [Abstract] [Full Text] [Related]

  • 18. Successful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without impairing patients' quality of life.
    Toyama Y, Yoshida S, Saito R, Kitamura H, Okui N, Miyake R, Ito R, Son K, Usuba T, Nojiri T, Yanaga K.
    World J Surg Oncol; 2013 Jan 09; 11():3. PubMed ID: 23302293
    [Abstract] [Full Text] [Related]

  • 19. Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic Cancer.
    Reyngold M, Karam SD, Hajj C, Wu AJ, Cuaron J, Lobaugh S, Yorke ED, Dickinson S, Jones B, Vinogradskiy Y, Shukla-Dave A, Do RKG, Sigel C, Zhang Z, Crane CH, Goodman KA.
    Int J Radiat Oncol Biol Phys; 2023 Sep 01; 117(1):53-63. PubMed ID: 36918130
    [Abstract] [Full Text] [Related]

  • 20. Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer.
    Mahadevan A, Miksad R, Goldstein M, Sullivan R, Bullock A, Buchbinder E, Pleskow D, Sawhney M, Kent T, Vollmer C, Callery M.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e615-22. PubMed ID: 21658854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.